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Abstract 
No report has been available regarding organ transplantation for atomic 
bomb survivors, even with renal graft. We experienced a living donor liver 
transplantation for two atomic bomb survivors using grafts from 
second-generation children. Post transplant course was uneventful without 
any systemic disorders under regular immunosuppression schema during 
3-year follow up. The detailed results are herein reported for the first time in 
the literature. 
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INTRODUCTION  
fter sixty years since atomic bomb exploded in Nagasaki, those 
survivors became old enough to suffer from end-stage liver disease, 
which required liver transplantation1,2. However, no report has been 
available regarding organ transplantation for atomic bomb survivors, even 
with renal graft. It has been reported that atomic bomb survivor might have 
significant immunological alteration, especially T cell function such as 
interleukin-2 production3. We recently performed living donor liver 
transplantation (LDLT) for 2 atomic bomb survivors. The detailed results are 
herein reported for the first time in the literature. 
 
CASE REPORT 
f 93 patients who had undergone LDLT in Nagasaki University 
Hospital (Nagasaki, Japan) between 1997 and October 2008, 2 
patients (2.2%) were atomic bomb survivor. A survivor was defined in the 
present study as a person who received the ‘Atomic Bomb Survivor’s Health 
Handbook’ produced by Nagasaki city authorities since the establishment of 
the Atomic Bomb Survivors’ Medical Treatment Law in April 1957. All 
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information, including exposure distance, had been recorded before the 
present study.  
The initial indication for LT was hepatocellular carcinoma in 
decompensated cirrhotic liver due to hepatitis B with model for end-stage 
liver disease (MELD) score of 19 in one patient, while it was due to hepatitis 
C in other patient with MELD score of 12 with intractable pleural effusion. 
The detailed information was described in Table 1. Since they were 
A-bombed in their childhood, both patients did not remember the wartime. 
Therefore, their psychiatric status before LDLT was stable. Usual thorough 
systemic survey was performed for both recipients, which included no 
specific additional screening. LDLT was performed with a right lobe graft 
without the middle hepatic vein for first patient in June, 2005 and with 
extended left lobe graft with middle hepatic vein for second patient in 
September, 2005. The living donors were a second generation son and a 
daughter of the recipients. HLA mismatches were 3 and 2, respectively. The 
first patient had been treated with tacrolimus based immunosuppression 
with trough level of 8-12 mg/dl during first 3 months and 5-8 ng/ml 
thereafter.  The second patient had been on cicrosporine with trough level 
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around 150 ng/ml within first 3 months and subsequent interferon treatment 
for hepatitis C recurrence4. Both patients have experienced neither acute 
cellular rejection nor fatal infection throughout the posttransplant course. 
Both patients have been well with normal liver function tests 3 years after 
the LDLT. Both recipients have undergone close follow-up using computed 




e feel it is responsible for medical doctors in Nagasaki to report 
the result of our intervention for atomic bomb survivors. By now, 
our both 2 patients have been well after liver transplantation with the 
allografts from living donor, who are second generation children. Since 
atomic bomb survivors have higher risk of multiple primary cancer 
development5, longer follow-up might be needed to ensure subsequent 
development of new cancer, on the top of susceptibility to cancer 
development in patients under immunosuppression. No immunological 
derangement or fetal infectious complications occurred after LDLT under 
W
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regular regimen of immunosuppression probably because our patients did 
not have T cell dysfunction as shown in Table 1. Since LDLT were performed 
in our case using allograft from second-generation children, we also need to 
make careful observation in the graft liver, which might also have a risk with 
genetic instability6. Therefore, careful surveillance for simultaneous cancer 
and follow-up after LDLT are needed for those patients. 
The exposure distance was used as a substitute for the estimated 
irradiated dose. Several unique epidemiological studies on Nagasaki 
survivors have already been documented with exposure distances5. In 
general, survivors who were less than 1.5 km from the hypocenter were 
exposed to a significant dose of radiation. The estimated doses in Nagasaki 
survivors who were not shielded at the time of explosion are: 924.7 cGy at 1.0 
km, 120.7 cGy at 1.5 km, 17.9 cGy at 2.0 km, and 2.9 cGy at 2.5 km from the 
hypocenter5. In our patients, the distance from the hypocenter was 2.5 and 
3.3 km. Since the distance was not too close, the influence between those 
patients and eradiation might not be strong. Latent period to develop 
hepatocellular carcinoma in case 1 patient was not unusual as compared to 
regular population of its development. 
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Usually, OLT might not be indicated for a patient with impaired T 
cell function. For example, patients with T cell dysfunction with human 
immunodeficiency virus sometimes can not be indicated for OLT to avoid 
opportunistic infection7. Therefore, if function of T cell is impaired in atomic 
bomb survivors, LDLT should not be done for the risk of infectious 
complication. Function of T cell could also decrease with aging, various 
stress and drugs etc. It needs further evidence for optimal 
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Table 1. Patient demographics and peripheral blood lymphocyte activation of the patients
Case 1 Case 2
Age  59 64
Gender     M F
Age at A-bomb 0 4
Distance from A-bomb     3.3km 2.5km
I di ti f LDLT HCC/LC B LC Cn ca on or - -
Living donor (Age) son (32) daughter (34)
CD4(%)/CD8(%) 35.0 / 43.4 (ratio 0.8) 28.0 / 32.9 (ratio 0.9)
T cell function tests
Con-A stimulation     57,430 64,535
SI (Con-A)     354.6 136.7
C t l 162 472on ro  
PHA stimulation     140,234 100,830
SI (PHA) 865.6 162
Control 162 472
A-bomb: atomic bomb LDLT: living donor liver transplantation HCC: hepatocellular carcinoma LC-B: liver  ,     ,   ,   
cirrhosis due to hepatitis B, LC-C: liver cirrhosis due to hepatitis CA-bomb: atomic bomb, LDLT: living donor 
liver transplantation, Con-A: concanavalin-A, PHA: phytohemagglutinin, 
SI: stimulation index, Normal range of SI  74.7-1793.2
